Oxaliplatin Active Not Recruiting Phase 2 / 3 Trials for Rectal Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT02017704Chemoradiation or Brachytherapy for Rectal Cancer
NCT02340949Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer
NCT01481545Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer